Skip to content
AiONAiON

Ozempic and Mounjaro side effects: what to expect and how to manage them

Ozempic and Mounjaro side effects: what to expect, how they are managed clinically and why proper medical follow-up makes all the difference.

Medically reviewed byDr. David Céspedes
Published
Mujer respirando en calma junto a la ventana: bienestar y acompañamiento

Introduction

If you are thinking about starting treatment with Ozempic, Mounjaro or any other GLP-1 receptor agonist, or you are already on treatment and are worried about the symptoms you are having, this article is for you. Side effects are a reality with these medicines, and they are also the main reason people stop treatment in the first few weeks.

The good news: most of them are manageable. The key is knowing what to expect, how to recognise them, when they are normal and when they call for urgent medical attention, and above all how they are minimised and managed with the right clinical strategies. This guide answers all of that with medical rigour, reviewed by Dr David Céspedes, Medical Director at AiON.

The bigger picture: why side effects happen

GLP-1 receptor agonists act on several body systems, which explains both how effective they are and their side effect profile. Most adverse effects are a direct consequence of their therapeutic mechanisms of action:

  • Slower gastric emptying: causes a feeling of fullness, reflux and sometimes nausea and vomiting.
  • Action on appetite centres in the brain: can cause fatigue, an initial feeling of weakness and occasionally mood changes.
  • Effects on bowel transit: diarrhoea or constipation depending on the individual response.

Gastrointestinal adverse effects are common: in the STEP-1 trial, 74.2% of patients treated with semaglutide experienced them (compared with 47.9% on placebo), mostly mild or moderate and concentrated in the dose escalation phase. Even so, only 5-7% stopped treatment for this reason. Source: Wilding JPH et al., New England Journal of Medicine 2021 (STEP-1).

Common side effects

Nausea

The most common side effect, particularly during gradual dose titration. It is usually mild to moderate and tends to ease off or disappear after the first 4 to 8 weeks. Roughly 20 to 40% of patients experience it at the start.

Management strategies:

  • Eat smaller, more frequent portions.
  • Avoid fatty, heavily spiced or very sweet foods in the first few weeks.
  • Eat slowly and chew thoroughly.
  • Avoid lying down immediately after eating.
  • Keep well hydrated, but in small sips rather than large amounts at once.
  • Ginger, as a tea or in capsules, may help some patients.
  • If it persists, your doctor can slow the titration or hold the dose steady for a while without increasing it.

Vomiting

Less common than nausea, but does occur in the initial phase. It tends to come in episodes. Roughly 10 to 20% of patients.

Management strategies:

  • All of the above measures for nausea apply.
  • Keep a close eye on hydration.
  • Speak to your doctor if it is frequent or is preventing you from eating properly.

Diarrhoea

A common effect, especially at higher doses. It is usually self-limiting and improves with time.

Management strategies:

  • Stay well hydrated with solutions containing electrolytes.
  • Avoid foods that may make it worse (dairy, spicy food, excessive caffeine, alcohol).
  • Speak to your doctor if it is severe or persistent.

Constipation

Paradoxically, this can also appear because of slower bowel transit. Similar frequency to diarrhoea.

Management strategies:

  • Increase your fibre intake (vegetables, fruit, pulses) as far as you can tolerate it.
  • Drink plenty of fluids.
  • Regular physical activity.
  • Magnesium supplementation may help (Coeus's Retromag is formulated specifically for this).

Reflux and a feeling of fullness

Caused by slower gastric emptying. Common, and usually mild.

Management strategies:

  • Small portions.
  • Do not lie down for at least 2 hours after eating.
  • Avoid the foods that individually make your reflux worse.
  • In persistent cases, your doctor may consider short-term gastric protection.

Fatigue in the early weeks

During the first few weeks, some patients report fatigue or weakness, linked to metabolic adaptation to the treatment and to the calorie deficit that develops.

Management strategies:

  • Make sure you get enough protein (1.2 to 1.6 grams per kilo of body weight).
  • Stay hydrated.
  • Do not cut your intake of complex carbohydrates drastically.
  • Electrolyte supplementation where appropriate.

Pain or discomfort at the injection site

Generally mild and short-lived. Some patients develop small nodules that disappear within days.

Management strategies:

  • Rotate the injection site (abdomen, thigh, arm).
  • Let the medicine come to room temperature before injecting (do not inject it straight from the fridge).
  • Correct injection technique.

Serious but uncommon side effects

Some side effects are uncommon but need urgent medical attention if they appear. It is important that anyone on treatment knows about them so they can recognise them.

Acute pancreatitis

Incidence: less than 1%. Symptoms: severe, persistent abdominal pain that may radiate to the back, with nausea and vomiting. Any severe abdominal pain in a patient on GLP-1 agonist treatment must be assessed urgently.

Gallbladder problems (gallstones, cholecystitis)

Rapid weight loss and GLP-1 agonists slightly increase the risk of gallstones. Symptoms: pain in the right upper abdomen, nausea, vomiting, intolerance of fatty foods. Requires medical assessment.

Thyroid changes

Animal studies showed a risk of thyroid tumours (medullary thyroid carcinoma) with these medicines. In humans the evidence is not conclusive, but as a precaution they are contraindicated in patients with a personal or family history of this tumour or of MEN-2 syndrome.

Hypoglycaemia

The risk is low when they are used on their own (the glucose-dependent mechanism keeps the risk to a minimum), but it can occur in patients with type 2 diabetes who are also taking insulin or sulphonylureas. Symptoms: sweating, tremor, confusion, sudden intense hunger.

Allergic reactions

Rare but possible. These range from skin rashes to serious reactions (angioedema, anaphylaxis). Any extensive skin reaction or breathing symptoms after the injection require urgent medical attention.

How side effects are managed clinically

The difference between a patient who tolerates treatment well and one who gives up in the third week usually comes down to the quality of medical follow-up. Standard clinical strategies to minimise side effects include:

Gradual dose titration

All GLP-1 agonists are started at low doses and increased gradually over weeks or months. This titration allows the body to adapt step by step and significantly reduces the incidence of side effects. Skipping titration steps to "go faster" is a common clinical mistake that leads to people dropping out.

Individualised adjustments

If a patient tolerates a dose poorly, the doctor can hold that dose for several extra weeks before increasing it, or go back temporarily to a lower dose. The regimen is flexible and should be adapted to the individual response.

Specific nutritional measures

A tailored nutrition plan markedly reduces digestive effects. Smaller portions, food quality, meal timing, structured hydration.

Complementary supplementation

Magnesium for nocturnal leg cramps (Retromag), enough protein to preserve muscle mass, electrolytes in cases of diarrhoea, short-term digestive support. A serious medical programme includes specific supplementation recommendations.

Accessible support to answer your questions

Many side effects cause unnecessary anxiety simply because the patient does not know whether they are normal or not. Having a channel to ask quickly (without waiting for the next appointment) is a decisive factor in adherence. Patients with access to ongoing support stop treatment significantly less often than those without it.

Differences between Ozempic and Mounjaro in side effect profile

The side effect profile is similar for both medicines, with some minor differences:

  • Mounjaro at high doses may be associated with a slightly higher incidence of gastrointestinal effects than Ozempic at usual doses.
  • However, when titration is done properly, the overall clinical difference is modest.
  • Individual tolerability varies widely: some patients tolerate one better than the other for reasons that are not fully understood.
  • Switching from one medicine to the other because of poor tolerability is a valid clinical option under medical supervision.

When to seek urgent medical advice

Not every side effect calls for an immediate consultation, but some symptoms do. You should contact your doctor urgently if you develop:

  • Severe, persistent abdominal pain, especially if it radiates to the back.
  • Vomiting that prevents you from staying hydrated for more than 24 hours.
  • Severe diarrhoea with signs of dehydration.
  • Severe pain in the gallbladder area, yellowing of the eyes, dark urine.
  • Extensive skin reactions or difficulty breathing.
  • Symptoms of severe hypoglycaemia in patients with diabetes.
  • Sudden changes in vision (in patients with diabetic retinopathy).
  • Suicidal ideation or behaviour (a very uncommon effect, but one that has been reported).

Adherence: the gap between the clinical trial and real life

There is a well documented gap between what is achieved in a clinical trial and what happens outside one:

  • In clinical trials, where patients receive close clinical follow-up, adherence is above 85%.
  • In real-world practice, without that support, close to half of patients have stopped by six months, and around two thirds by one year (Gleason PP et al., Journal of Managed Care & Specialty Pharmacy, 2024).

It is worth being honest about what that gap does and does not show. Trial participants are selected, receive the medication free of charge and do not face supply shortages, so the difference cannot be put down to follow-up alone: no trial has measured this. What we do know is that effectiveness depends on completing the plan, and that giving up in week four because of manageable nausea means losing the benefit and going back to square one. That is why we built AiON around ongoing support: it is our design principle in the face of that gap, not a promise of results.

How well the treatment works depends on completing the plan. Giving up in week four because of manageable nausea means losing the full benefit of the treatment and going back to square one.

What sets a serious medical protocol apart

The criteria that mark out a proper medical programme in terms of side effect management are:

  • A full and honest explanation of the side effects you can expect before you start.
  • A titration plan tailored to your tolerability.
  • Genuine medical availability for questions between scheduled appointments.
  • 24/7 support to answer questions the moment they come up.
  • Specific supplementation and nutrition recommendations to ease side effects.
  • Flexibility to adjust the regimen according to individual response.
  • A clear plan of what to do if serious effects appear.

Conclusion

The side effects of Ozempic and Mounjaro are real, they are common particularly in the early phase, and they are the main reason people stop treatment prematurely. But the vast majority are also manageable with well established clinical strategies and appropriate medical follow-up.

The difference between successful and unsuccessful treatment usually lies not in which medicine is chosen, but in the quality of the clinical support. A patient who can reach their doctor to sort out persistent nausea in week 3 has very different odds of completing treatment than one who is reading forums at 3 in the morning wondering whether what they are feeling is normal.

The clinical recommendation is clear: these treatments should only be carried out under genuine medical supervision, with ongoing follow-up, accessible support and a comprehensive plan. Any service that offers them without these components is compromising both safety and effectiveness.

Side effects are manageable, but they require genuine medical follow-up

With Peso, follow-up is daily with the medical team, available 24/7 through AiON to answer your questions as they arise. Our medical team, overseen by Medical Director Dr David Céspedes, supports every phase of treatment with personalised adjustments based on your individual response. If you are not a clinical candidate, you pay nothing.

Frequently asked questions

How long do the side effects of Ozempic and Mounjaro last?

Most side effects (nausea, fatigue, digestive discomfort) are at their most intense during the titration phase and tend to ease off or disappear after 4 to 8 weeks, as the body adapts.

Can I take anti-sickness medication for nausea?

Only if your doctor tells you to. Some anti-sickness medicines can be used occasionally, but the main strategy should be adjusting titration and diet. Your doctor will advise you on what to do in your case.

Are side effects worse with Mounjaro than with Ozempic?

They are slightly more common with Mounjaro at high doses, but the overall clinical difference is modest when titration is done correctly. Individual tolerability varies a great deal.

What happens if I cannot tolerate the treatment?

There are options: adjusting the titration schedule, switching to another agonist with a different profile, or considering non-drug strategies. The decision is made together with your doctor.

Do side effects go away when you stop the medicine?

Yes, most gastrointestinal side effects disappear quickly once treatment is stopped. Serious effects are uncommon and require specific medical assessment.

Your next step

The difference between suffering side effects and managing them well usually comes down to the same thing: having a medical team alongside you from day one. Medical weight loss treatment is now available in Spain, with a prior assessment, a prescription where appropriate from a registered doctor and ongoing follow-up from the medical team. You can check whether you are eligible in 30 seconds.

This content is for information and general education. It is in no way a substitute for professional medical advice, diagnosis or treatment. The medicines mentioned in this article are prescription-only medicines in Spain and can only be dispensed with an official prescription issued by an authorised healthcare professional. Always consult an endocrinologist before starting any weight loss treatment. If you are on treatment with any of these medicines and are experiencing side effects that worry you, contact your prescribing doctor immediately.

It's time to reach your goal.

Online medical assessment, prescription when appropriate and 1:1 follow-up with this team.

Start assessment